Resistance to EGFR Inhibitors: Fitness, Competition, and Diversity

被引：1
|
作者：
Le, Xiuning [1 ,2 ]
机构：
[1] Univ Texas Houston, MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX USA
[2] Univ Texas Houston, MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 04期
关键词：
CELL LUNG-CANCER; MUTATION; OUTCOMES;
D O I：
10.1016/j.jtho.2023.01.006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：390 / 392
页数：3
相关论文
共 50 条
  • [21] Mechanisms of Intrinsic and Acquired Resistance to EGFR Inhibitors
    Morgillo, Floriana
    Tortora, Giampaolo
    Ciardiello, Fortunato
    CURRENT CANCER THERAPY REVIEWS, 2007, 3 (04) : 276 - 283
  • [22] Design and synthesis of quinazolinones as EGFR inhibitors to overcome EGFR resistance obstacle
    Patel, Harun M.
    Pawara, Rahul
    Ansari, Azim
    Noolvi, Malleshappa
    Surana, Sanjay
    BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (10) : 2713 - 2723
  • [23] ABILITY OF THE MET KINASE INHIBITOR CRIZOTINIB AND NEW GENERATION EGFR INHIBITORS TO OVERCOME RESISTANCE TO EGFR INHIBITORS
    Nanjp, Shigeki
    Yamada, Tadaaki
    Nishihara, Hiroshi
    Takeuchi, Shinji
    Ebi, Hiromichi
    Yano, Seiji
    RESPIROLOGY, 2013, 18 : 47 - 47
  • [24] Ability of the Met Kinase Inhibitor Crizotinib and New Generation EGFR Inhibitors to Overcome Resistance to EGFR Inhibitors
    Nanjo, Shigeki
    Yamada, Tadaaki
    Nishihara, Hiroshi
    Takeuchi, Shinji
    Sano, Takako
    Nakagawa, Takayuki
    Ishikawa, Daisuke
    Zhao, Lu
    Ebi, Hiromichi
    Yasumoto, Kazuo
    Matsumoto, Kunio
    Yano, Seiji
    PLOS ONE, 2013, 8 (12):
  • [25] Targeting EGFR with molecular degraders as a promising strategy to overcome resistance to EGFR inhibitors
    Wang, Qiangfeng
    Zhu, Yumeng
    Pei, Junping
    FUTURE MEDICINAL CHEMISTRY, 2024, 16 (18) : 1923 - 1944
  • [26] Acquired resistance to EGFR inhibitors: Mechanisms and prevention strategies
    Viloria-Petit, AM
    Kerbel, RS
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (03): : 914 - 926
  • [27] EGFR Tyrosine Kinase Inhibitors: Difference in Efficacy and Resistance
    Kyle W. Robinson
    Alan B. Sandler
    Current Oncology Reports, 2013, 15 : 396 - 404
  • [28] Combination of EGFR signaling pathway inhibitors and prevention of resistance
    Cornelissen, Bart
    CANCER BIOLOGY & THERAPY, 2009, 8 (06) : 531 - 532
  • [29] MECHANISMS OF RESISTANCE TO EGFR INHIBITORS IN HEAD AND NECK CANCER
    Cooper, Jonathan B.
    Cohen, Ezra Eddy Wyssam
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2009, 31 (08): : 1086 - 1094
  • [30] Resistance is futile with fourth-generation EGFR inhibitors
    Michelangelo Marasco
    Sandra Misale
    Nature Cancer, 2022, 3 : 381 - 383
12345